Cover Image
市場調查報告書

Northern Antibiotics Oy - 產品平台分析

Northern Antibiotics Oy - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 310647
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Northern Antibiotics Oy - 產品平台分析 Northern Antibiotics Oy - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 20 Pages
簡介

Northern Antibiotics Oy,是開發革蘭氏陰性菌感染疾病治療性化合物的研究開發企業。主要針對透過綠膿菌,革蘭氏陰性腸內細菌,鮑氏不動桿菌的活動之化合物。該公司更致力於與國立抗菌·預防感染·血清學研究所合作,致力於研究·開發。

本報告提供Northern Antibiotics Oy的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Northern Antibiotics Oy的基本資料

Northern Antibiotics Oy概要

  • 主要資訊
  • 企業資料

Northern Antibiotics Oy:R&D概要

  • 主要的治療範圍

Northern Antibiotics Oy:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Northern Antibiotics Oy:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Northern Antibiotics Oy:藥物簡介

  • NAB-7061
  • NAB-739
  • NAB-741

Northern Antibiotics Oy:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Northern Antibiotics Oy:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07168CDB

Summary

Global Markets Direct's, 'Northern Antibiotics Oy - Product Pipeline Review - 2015', provides an overview of the Northern Antibiotics Oy's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Northern Antibiotics Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Northern Antibiotics Oy including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Northern Antibiotics Oy's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Northern Antibiotics Oy's pipeline products

Reasons to buy

  • Evaluate Northern Antibiotics Oy's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Northern Antibiotics Oy in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Northern Antibiotics Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Northern Antibiotics Oy and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northern Antibiotics Oy
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Northern Antibiotics Oy and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Northern Antibiotics Oy Snapshot
    • Northern Antibiotics Oy Overview
    • Key Information
    • Key Facts
  • Northern Antibiotics Oy - Research and Development Overview
    • Key Therapeutic Areas
  • Northern Antibiotics Oy - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Northern Antibiotics Oy - Pipeline Products Glance
    • Northern Antibiotics Oy - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Northern Antibiotics Oy - Drug Profiles
    • NAB-7061
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NAB-739
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NAB-741
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Northern Antibiotics Oy - Pipeline Analysis
  • Northern Antibiotics Oy - Pipeline Products by Target
  • Northern Antibiotics Oy - Pipeline Products by Molecule Type
  • Northern Antibiotics Oy - Pipeline Products by Mechanism of Action
  • Northern Antibiotics Oy - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Northern Antibiotics Oy, Key Information
  • Northern Antibiotics Oy, Key Facts
  • Northern Antibiotics Oy - Pipeline by Indication, 2015
  • Northern Antibiotics Oy - Pipeline by Stage of Development, 2015
  • Northern Antibiotics Oy - Monotherapy Products in Pipeline, 2015
  • Northern Antibiotics Oy - Preclinical, 2015
  • Northern Antibiotics Oy - Pipeline by Target, 2015
  • Northern Antibiotics Oy - Pipeline by Molecule Type, 2015
  • Northern Antibiotics Oy - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Northern Antibiotics Oy - Pipeline by Top 10 Indication, 2015
  • Northern Antibiotics Oy - Pipeline by Top 10 Molecule Type, 2015
Back to Top